Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Shell (UK) | 1.70% | $4.51M | £175.51B | 21.16% | 73 Outperform | |
| AstraZeneca | 1.65% | $4.36M | $312.86B | 25.09% | 80 Outperform | |
| Roche Holding AG | 1.58% | $4.18M | CHF283.97B | 35.98% | 73 Outperform | |
| Novartis AG | 1.51% | $3.99M | CHF240.57B | 27.68% | 80 Outperform | |
| Engie SA | 1.35% | $3.58M | €68.93B | 59.57% | 64 Neutral | |
| TOKYO GAS Co | 1.26% | $3.33M | ¥2.91T | 75.13% | 77 Outperform | |
| Canadian Natural | 1.23% | $3.27M | C$125.74B | 61.06% | 81 Outperform | |
| Endesa SA | 1.19% | $3.15M | €35.24B | 57.90% | 63 Neutral | |
| Italgas S.p.A. | 1.15% | $3.05M | €10.57B | 77.63% | 67 Neutral | |
| Centrica | 1.13% | $3.00M | £8.72B | 31.46% | 66 Neutral |